Gangstem Biotech, Patent on Method for Manufacturing Induced Neural Stem Cells

[Asia Economy Reporter Oh Ju-yeon] Kangstem Biotech announced on the 14th that it has obtained a domestic patent for a method of producing neural stem cells induced from non-neural cells through direct programming and its applications. The company stated, "By precisely controlling the amount of virus containing Sox2 and c-Myc, neural stem cells can be produced solely by the introduction of Sox2 and c-Myc, and the genetic stability and differentiation ability of the produced induced neural stem cells can be confirmed."